Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
BURT, BRYAN
One or more keywords matched the following properties of BURT, BRYAN
PropertyValue
keywords • Tumor immunology • Non-small cell lung cancer • Malignant pleural mesothelioma
overview Dr. Bryan Burt’s research efforts concentrate on immunologic determinants of pleural mesothelioma and non-small cell lung cancer; he is currently focusing efforts on novel therapeutic intraoperative treatments of pleural mesothelioma.
One or more keywords matched the following items that are connected to BURT, BRYAN
Item TypeName
Concept Mesothelioma
Academic Article Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
Academic Article Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation.
Academic Article Clinical indications and results after chest wall resection for recurrent mesothelioma.
Academic Article Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
Academic Article CTLA4 blockade in patients with malignant mesothelioma.
Academic Article Invited Commentary.
Academic Article Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.
Academic Article Therapeutic R2 resection for pleural mesothelioma.
Academic Article Intraoperative adjuncts for malignant pleural mesothelioma.
Academic Article Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.
Academic Article Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.
Academic Article A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.
Academic Article Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
Academic Article To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma.
Academic Article A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.
Grant Allogeneic antibody therapy for malignant mesothelioma
Academic Article Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention.
Academic Article A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.
Academic Article Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.
Academic Article Commentary: Focused attention on proactive identification of deep venous thrombosis after pleurectomy/decortication for malignant pleural mesothelioma.
Academic Article Preoperative prediction of unresectability in malignant pleural mesothelioma.
Academic Article Reply to Waller et?al. Standardizing Surgical Treatment for Mesothelioma.
Academic Article Malignant Pleural Mesothelioma.
Academic Article Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging.
Academic Article Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma.
Grant Proteomic determinants of response to checkpoint blockade in malignant pleural mesothelioma
Academic Article Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling.
Academic Article Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant Mesothelioma.
Academic Article Checkpoint blockade in unresectable pleural mesothelioma: Event horizon for multimodal therapy.
Academic Article A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma.
Academic Article A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.
Academic Article Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors.
Academic Article Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy.
Academic Article Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma.
Search Criteria
  • Mesothelioma